Skip to main content
. 2021 Jul 22;8:713187. doi: 10.3389/fcvm.2021.713187

Figure 2.

Figure 2

Subgroup analysis based on different types of DOACs regarding the risk of fractures of DOACs vs. VKAs in AF patients. AF, atrial fibrillation; DOACs, direct oral anticoagulants; VKAs, vitamin K antagonists; DA, dabigatran; RIV, rivaroxaban; API, apixaban; EDO, edoxaban; CI, confidence interval; SE, standard error; IV, inverse of the variance.